Where can I buy GMed shares?
Real time GeneMedicine, Inc. (GMED) stock price quote, stock graph, news & analysis.
What's happening with global medical stock?
Apr 06, 2022 · GMED | Complete Globus Medical Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
What is the price of gmedus in 2022?
Mar 18, 2022 · Their forecasts range from $74.00 to $100.00. On average, they expect Globus Medical's stock price to reach $85.36 in the next twelve months. This suggests a possible upside of 24.6% from the stock's current price. View analysts' price targets for Globus Medical or view top-rated stocks among Wall Street analysts.
What are analysts'target prices for Globus Medical's stock?
Real time Globus Medical (GMED) stock price quote, stock graph, news & analysis.
Is Globus Medical a buy right now?
11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Globus Medical in the last year. There are currently 1...
How has Globus Medical's stock price been impacted by COVID-19 (Coronavirus)?
Globus Medical's stock was trading at $38.05 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health...
Are investors shorting Globus Medical?
Globus Medical saw a drop in short interest in the month of February. As of February 28th, there was short interest totaling 951,500 shares, a drop...
When is Globus Medical's next earnings date?
Globus Medical is scheduled to release its next quarterly earnings announcement on Tuesday, May 3rd 2022. View our earnings forecast for Globus Me...
How were Globus Medical's earnings last quarter?
Globus Medical, Inc. (NYSE:GMED) posted its earnings results on Thursday, February, 17th. The medical device company reported $0.49 EPS for the qua...
What guidance has Globus Medical issued on next quarter's earnings?
Globus Medical issued an update on its FY 2022 earnings guidance on Thursday, March, 10th. The company provided EPS guidance of $2.100-$2.100 for t...
What price target have analysts set for GMED?
11 Wall Street analysts have issued 12-month price objectives for Globus Medical's shares. Their forecasts range from $74.00 to $100.00. On average...
Who are Globus Medical's key executives?
Globus Medical's management team includes the following people: David M. Demski , President, Chief Executive Officer & Director ( LinkedIn Profi...
What is David Demski's approval rating as Globus Medical's CEO?
47 employees have rated Globus Medical CEO David Demski on Glassdoor.com . David Demski has an approval rating of 61% among Globus Medical's emplo...
Is Globus Medical a buy right now?
What stocks does MarketBeat like better than Globus Medical?
11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Globus Medical in the last year. There are currently 3 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Globus Medical stock.#N#View analyst ratings for Globus Medical or view top-rated stocks.
Are investors shorting Globus Medical?
Wall Street analysts have given Globus Medical a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Globus Medical wasn't one of them.
When is Globus Medical's next earnings date?
Globus Medical saw a drop in short interest in the month of August. As of August 13th, there was short interest totaling 1,160,000 shares, a drop of 17.1% from the July 29th total of 1,400,000 shares. Based on an average daily volume of 393,900 shares, the short-interest ratio is currently 2.9 days.
How were Globus Medical's earnings last quarter?
Globus Medical is scheduled to release its next quarterly earnings announcement on Wednesday, October 27th 2021.#N#View our earnings forecast for Globus Medical.
How has Globus Medical's stock been impacted by Coronavirus?
Globus Medical, Inc. (NYSE:GMED) posted its quarterly earnings data on Wednesday, August, 4th. The medical device company reported $0.56 EPS for the quarter, topping the Zacks' consensus estimate of $0.44 by $0.12. The medical device company earned $251.02 million during the quarter, compared to analyst estimates of $225.50 million.
What guidance has Globus Medical issued on next quarter's earnings?
Globus Medical's stock was trading at $38.05 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, GMED shares have increased by 119.9% and is now trading at $83.69.#N#View which stocks have been most impacted by COVID-19.
Signals & Forecast
Globus Medical issued an update on its FY 2021 earnings guidance on Wednesday, September, 1st. The company provided earnings per share guidance of $2.000-$2.000 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.890.
Support, Risk & Stop-loss
The Globus Medical Inc stock holds a sell signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock.
Is Globus Medical Inc stock A Buy?
Globus Medical Inc finds support from accumulated volume at $79.90 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
Premium Research for GMED
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Globus Medical Inc stock to perform well in the short-term.
Company Summary
This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
